Oncopeptides AB (publ) (STO:ONCO)
Sweden
· Delayed Price · Currency is SEK 1.470
-0.050 (-3.29%)
Jun 13, 2025, 5:29 PM CET
Oncopeptides AB Revenue
Oncopeptides AB had revenue of 13.27M SEK in the quarter ending March 31, 2025, with 161.57% growth. This brings the company's revenue in the last twelve months to 39.84M, up 1.72% year-over-year. In the year 2024, Oncopeptides AB had annual revenue of 31.65M, down -10.14%.
Revenue (ttm)
39.84M
Revenue Growth
+1.72%
P/S Ratio
8.33
Revenue / Employee
531.24K
Employees
80
Market Cap
331.87M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.31B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Camurus AB | 2.04B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vimian Group AB | 4.24B |
Oncopeptides AB News
- 7 months ago - Oncopeptides AB (STU:OND) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic Market ... - GuruFocus
- 7 months ago - Q3 2024 Oncopeptides AB Earnings Call Transcript - GuruFocus
- 10 months ago - Oncopeptides AB (OSTO:ONCO) Q2 2024 Earnings Call Transcript Highlights: Revenue Surge and ... - GuruFocus
- 10 months ago - Q2 2024 Oncopeptides AB Earnings Call Transcript - GuruFocus